Table 5

Total 5-aminosalicylic acid (5-ASA +N-acetyl-5-ASA) faecal and urinary recovery (as percentage of ingested dose) of Asacol, Pentasa, and olsalazine in volunteers with normal or rapid transit time (TT) and in patients with inactive or active ulcerative colitis

  • Data taken from references48–54